Gurvinder Kaur

2.7k citations
62 papers · 1.8k indexed · h-index 27
Topics
Meningioma and schwannoma management (27 papers)Glioma Diagnosis and Treatment (21 papers)Neurofibromatosis and Schwannoma Cases (13 papers)

In The Last Decade

Gurvinder Kaur

57 papers receiving 1.8k citations

Peers

Gurvinder Kaur
Comparison fields: 5 of 102
  • Epidemiology 731
  • Genetics 614
  • Neurology 532
  • Surgery 443
  • Immunology 285
Replace Marc Polivka with:
Marc Polivka France
Giuseppe Broggi Italy
Mila Blaivas United States
Hidehiro Oka Japan
Murat Gökden United States
Christopher Duma United States
Shin Ishizawa Japan
Massimo Gerosa Italy
Lucio Palma Italy
Ken-ichi Iyama Japan
Gurvinder Kaur relative to Marc Polivka France Marc Polivka's profile →
Citations per field
00.5×4.5×
Marc Polivka · 1×
Citations per year

Countries citing papers authored by Gurvinder Kaur

Since Specialization
Citations

This map shows the geographic impact of Gurvinder Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurvinder Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurvinder Kaur more than expected).

Fields of papers citing papers by Gurvinder Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gurvinder Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurvinder Kaur. The network helps show where Gurvinder Kaur may publish in the future.

Co-authorship network of co-authors of Gurvinder Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Gurvinder Kaur. A scholar is included among the top collaborators of Gurvinder Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurvinder Kaur. Gurvinder Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 20
5 16
6 6
7 137
8 15
9
Therapeutic potential of immune privileged Sertoli cells
7
10 154
11 16
12 15
13 12
14 32
15 27
16 39
17 41
18 59
19 57
20 76

About Gurvinder Kaur

Gurvinder Kaur is a scholar working on Genetics, Neurology and Epidemiology, having authored 62 papers that have together received 1.8k indexed citations. Recurring topics across this work include Meningioma and schwannoma management (27 papers), Glioma Diagnosis and Treatment (21 papers) and Neurofibromatosis and Schwannoma Cases (13 papers). The work is most often cited by research in Genetics (614 citations), Neurology (532 citations) and Epidemiology (731 citations). Gurvinder Kaur has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Andrew T. Parsa, Orin Bloch, Matthew Z. Sun, Michael Safaee, Michael C. Oh, Eli T. Sayegh, Rajwant Kaur, Isaac Yang, Michael E. Ivan and Joseph M. Kim. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026